Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01224561
Other study ID # 0701047
Secondary ID 2007-A00744-49DG
Status Completed
Phase N/A
First received October 18, 2010
Last updated May 4, 2011
Start date March 2008
Est. completion date January 2011

Study information

Verified date May 2011
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)France: French Data Protection AuthorityFrance: Ministry of Health
Study type Observational

Clinical Trial Summary

For a given food intake, fat and energy metabolism in adipose tissue and muscle adapt to nutrient intakes. This adaptation to nutrition may be impaired in susceptible individuals or in obese patients by promoting weight gain, either in constitutional thinness (MC) by blocking it. The MC is a little known entity. These patients wish to grow for her and others. Can they? We have demonstrated abnormalities of hormones regulating appetite (ghrelin, PYY, GLP1 and leptin) that may participate in thinness. Furthermore, this thinness is associated with osteoporosis in 25% of true MC who is 25 years old.


Description:

This project aims to overfed MCs and follow the control parameters of energy metabolism. We will look for abnormalities in the adaptation to overnutrition in subjects with genetic background of thinness, which could explain the resistance to weight gain. The answer could possibly help to understand obesity.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date January 2011
Est. primary completion date January 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- consent form the study signed

- consent form for genetic study signed

- normal laboratory values for liver enzymes, glucose, lipid

Exclusion Criteria (common to the two groups):

- pregnant

- vegetarian

- heavy smoking

- heavy alcohol

- depressive

- taking hypolipidemic or antihypertensive drugs

- dyslipidemia

Study Design

Time Perspective: Prospective


Intervention

Behavioral:
Lipid overnutrition
During 4 months, the daily caloric intake will be increased by about 70 g fat as butter 20 grams, 100 grams of cheese (Emmental) and 40 grams of almonds. This overnutrition corresponds to an excess of 760 kcal / day or 21,280 calories for the period and then taken to a theoretical 2.4 kg of fat (1 kg fat = 9000 kcal).

Locations

Country Name City State
France CRNH Auvergne Clermont-Ferrand
France CRNH Rhône-Alpes Lyon
France CHU de Saint-Etienne Saint-etienne

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne Ministry of Health, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary gene expression Level of genes (which regulate the lipid and energy metabolism) expression in fat and muscle tissues After one month of lipid overnutrition No
Secondary Anthropometric parameter Lean mass After one month of lipid overnutrition No
Secondary Autonomic nervous system activity Heart rate variability analyses using ECG Holter monitoring After one month of lipid overnutrition No
Secondary gastrointestinal hormone level Serum level of GLP1 After one month of lipid overnutrition No
Secondary Anthropometric parameter Weight After one month of lipid overnutrition No
Secondary Anthropometric parameter Fat mass After one month of lipid overnutrition No
Secondary gastrointestinal hormone level Serum level of ghréline After one month of lipid overnutrition No
Secondary gastrointestinal hormone level Serum level of PYY After one month of lipid overnutrition No